Search results for "antiviral agent"

showing 10 items of 505 documents

Thoughts on What Chemists Can Contribute to Fighting SARS-CoV-2 - A Short Note on Hand Sanitizers, Drug Candidates and Outreach.

2020

Abstract The SARS‐CoV‐2 outbreak causing the respiratory disease COVID‐19 has left many chemists in academia without an obvious option to contribute to fighting the pandemic. Some of our recent experiences indicate that there are ways to overcome this dilemma. A three‐pronged approach is proposed.

DNA Replication2019-20 coronavirus outbreakCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Hand SanitizersPneumonia Viral010402 general chemistry01 natural sciencesAntiviral AgentsCatalysisalcohols2-PropanolBetacoronavirusViewpointantiviralsPolitical sciencePandemicHumansPandemicshealth care economics and organizationsEthanol010405 organic chemistrybusiness.industrySARS-CoV-2pandemicCOVID-19General MedicineGeneral ChemistryDNA-Directed RNA PolymerasesPublic relations0104 chemical sciencesDilemmaOutreachViewpointsChemists in the CommunitybusinessCoronavirus InfectionsdisinfectantsCoronavirus InfectionsAngewandte Chemie (International ed. in English)
researchProduct

The broad-spectrum antiinfective drug artesunate interferes with the canonical nuclear factor kappa B (NF-κB) pathway by targeting RelA/p65.

2015

Infection with human cytomegalovirus (HCMV) is a serious medical problem, particularly in immunocompromised individuals and neonates. The success of standard antiviral therapy is hampered by low drug compatibility and induction of viral resistance. A novel strategy is based on the exploitation of cell-directed signaling inhibitors. The broad antiinfective drug artesunate (ART) offers additional therapeutic options such as oral bioavailability and low levels of toxic side-effects. Here, novel ART-derived compounds including dimers and trimers were synthesized showing further improvements over the parental drug. Antiviral activity and mechanistic aspects were determined leading to the followi…

DrugHuman cytomegalovirusTranscriptional Activationmedia_common.quotation_subjectTranscription Factor RelAArtesunateCytomegalovirusPharmacologyCREBAntiviral Agentschemistry.chemical_compoundVirologyDrug Resistance ViralmedicineHumansCyclic AMP Response Element-Binding ProteinHerpesviridaemedia_commonPharmacologybiologyHEK 293 cellsNF-kappa BTranscription Factor RelANF-κBmedicine.diseaseIn vitroArtemisininsUp-RegulationHEK293 CellschemistryMutationbiology.proteinSignal transductionSignal TransductionAntiviral research
researchProduct

Microscopic interactions between ivermectin and key human and viral proteins involved in SARS-CoV-2 infection

2021

The identification of chemical compounds able to bind specific sites of the human/viral proteins involved in the SARS-CoV-2 infection cycle is a prerequisite to design effective antiviral drugs. Here we conduct a molecular dynamics study with the aim to assess the interactions of ivermectin, an antiparasitic drug with broad-spectrum antiviral activity, with the human Angiotensin-Converting Enzyme 2 (ACE2), the viral 3CLpro and PLpro proteases, and the viral SARS Unique Domain (SUD). The drug/target interactions have been characterized in silico by describing the nature of the non-covalent interactions found and by measuring the extent of their time duration along the MD simulation. Results …

DrugProteasesIn silicomedia_common.quotation_subjectProtein domainCoronavirus Papain-Like ProteasesGeneral Physics and AstronomyPlasma protein bindingBiologyAntiviral AgentsivermectinProtein DomainsMolecular dynamics simulationHumansPhysical and Theoretical ChemistryBinding siteCoronavirus 3C Proteasesmedia_commonchemistry.chemical_classificationSARS Unique DomainBinding SitesSARS-CoV-2SARS-CoV-2 infectionRNAHydrogen BondingVirologyG-QuadruplexesMolecular Docking SimulationEnzymechemistrySettore CHIM/03 - Chimica Generale E InorganicaRNAAngiotensin-Converting Enzyme 2Hydrophobic and Hydrophilic InteractionsProtein BindingPhysical Chemistry Chemical Physics
researchProduct

Biowaiver Monographs for Immediate Release Solid Oral Dosage Forms: Aciclovir

2008

Literature data relevant to the decision to allow a waiver of in vivo bioequivalence (BE) testing (biowaiver) for the approval of immediate release (IR) solid oral dosage forms containing aciclovir are reviewed. Aciclovir therapeutic use and therapeutic index, pharmacokinetic properties, data related to the possibility of excipient interactions and reported BE/bioavailability (BA) studies were also taken into consideration in order to ascertain whether a biowaiver can be recommended. According to the Biopharmaceutics Classification System (BCS) and considering tablet strengths up to 400 mg, aciclovir would be BCS Class III. However, in some countries also 800 mg tablets are available which …

Drugbusiness.industrymedia_common.quotation_subjectAcyclovirAdministration OralBiological Availabilityvirus diseasesPharmaceutical ScienceExcipientPharmacologyBioequivalenceBiopharmaceutics Classification SystemAntiviral AgentsDosage formTherapeutic EquivalencyPharmacokineticsmedicineRegulatory scienceAciclovirbusinessmedicine.drugmedia_commonJournal of Pharmaceutical Sciences
researchProduct

Failure of Cytomegalovirus-Specific CD8+ T Cell Levels at Viral DNAemia Onset to Predict the Eventual Need for Preemptive Antiviral Therapy in Alloge…

2018

Enzyme-Linked Immunospot Assaymedicine.medical_treatmentCongenital cytomegalovirus infectionCytomegalovirusHematopoietic stem cell transplantationCD8-Positive T-Lymphocytes030230 surgeryAntiviral Agents03 medical and health sciences0302 clinical medicineCorrespondencemedicineHumansImmunology and AllergyCytotoxic T cellbusiness.industryHematopoietic Stem Cell TransplantationAntiviral therapyCmv dnaemiamedicine.diseaseTransplant RecipientsInfectious DiseasesCytomegalovirus InfectionsImmunology030211 gastroenterology & hepatologyCytomegalovirus infectionsAllogeneic hematopoietic stem cell transplantEnzyme linked immunospot assaybusinessThe Journal of Infectious Diseases
researchProduct

Ethnopharmacology, phytochemistry and biological activity of Erodium species: a review

2019

Erodium spp. is a genus that can be found in all continents that has been traditionally used in folk medicine to treat many diseases such as hemorrhage, dermatological disorders, indigestion, and inflammatory diseases. Moreover, Erodium leaves have been used for the preparation of salads, omelets, sandwiches, sauces and soups, among other food products. The objective of this review was to show the recent and relevant studies about extraction of bioactive compounds, the phytochemical characterization, the potential biological activities and toxicological evidence reported in both in vitro and in vivo studies from Erodium spp. In addition, the use of Erodium spp. as natural compounds against …

ErodiumPhytochemistryTECNOLOGIA DE ALIMENTOSmedicine.drug_classErodiumFood spoilagePhytochemicalsAnti-Inflammatory AgentsAntiviral AgentsAnti-inflammatoryAntioxidantsAnti-Infective AgentsmedicineOils VolatileHumansAntiviralGeraniaceaeTraditional medicineCarminativebiologyPlant ExtractsBiological activitybiology.organism_classificationAntimicrobialAnti-inflamatoryPhenolic compoundsPlant LeavesPhytochemicalEthnopharmacologyAntimicrobialMedicine TraditionalAnti-inflammatoryTraditional useFood SciencePhytotherapy
researchProduct

Antiviral activity of aged green tea extract in model food systems and under gastric conditions.

2018

Aged-green tea extract (GTE) is known to reduce the infectivity of hepatitis A virus (HAV) and murine norovirus (MNV), a human norovirus surrogate, in vitro and in washing solutions. Initially, the effect of aged-GTE was evaluated on virus like particles (VLPs) of human norovirus (HuNoV) genogroup I (GI) by a porcine gastric mucine (PGM)-enzyme-linked immunosorbent assay (ELISA) and transmission electron microscopy (TEM), and on HuNoV GI suspensions by an in situ capture-RT-qPCR method, suggesting that HuNoVs are very sensitive to aged-GTE treatment at 37 °C. Moreover, the potential application of aged-GTE was evaluated using model foods and simulated gastric conditions. Then, aged-GTE samp…

Food Handlingvirusesved/biology.organism_classification_rank.speciesGreen tea extractmedicine.disease_causeMicrobiologyAntiviral AgentsVirusCell LineFoodborne Diseases03 medical and health sciencesMicemedicineAnimalsFood scienceFood model systems030304 developmental biologyInfectivityOrange juice0303 health sciencesTea030306 microbiologyved/biologyChemistryPlant ExtractsNorovirusSimulated gastric fluidGeneral MedicineMacaca mulattaIn vitroFruit and Vegetable JuicesTiterMilkRAW 264.7 CellsNorovirusHuman norovirusHepatitis A virusGreen tea extractFood ScienceMurine norovirusInternational journal of food microbiology
researchProduct

Rapid development of Epstein-Barr virus-associated Hodgkin's disease after cessation of foscarnet therapy in an HIV-infected patient.

2000

Epidemiological features suggest a link between Hodgkin's disease (HD) and Epstein-Barr virus (EBV) infection1. Indeed, EBV genome and expression of latent antigens can be found in Reed-Sternberg cells. In the majority of cases HD in HIV patients seems to be EBV-associated. We report on a 51-year-old HIV-infected patient in whom EBV-positive HD of mixed cellularity rapidly developed within one month after cessation of treatment with intravenous foscarnet.

FoscarnetMaleEpstein-Barr Virus InfectionsHIV InfectionsDermatologymedicine.disease_causeAntiviral AgentsVirusHerpesviridaehemic and lymphatic diseasesMedicineHumansPharmacology (medical)Sidabiologybusiness.industryPublic Health Environmental and Occupational HealthMiddle Agedmedicine.diseasebiology.organism_classificationEpstein–Barr virusVirologyHodgkin DiseaseLymphomaInfectious DiseasesFoscarnet SodiumImmunologyViral diseasebusinessmedicine.drugFoscarnetInternational journal of STDAIDS
researchProduct

Implementation and microbiological stability of dose-banded ganciclovir infusion bags prepared in series by a robotic system.

2018

Objectives The implementation of dose-banding (DB) in centralised, pharmacy-based cytotoxic drug preparation units allows the preparation of standardised doses in series. The aim of this study was to evaluate the feasibility of DB for the prescribing of ganciclovir (GV) infusion solutions and to investigate the microbiological stability of dose-banded, automatically prepared ready-to-administer GV infusion bags by media-fill simulation tests and sterility tests. Methods The frequency of prescription of GV doses was retrospectively analysed before and after implementing the DB scheme. Four dose-ranges or ‘bands’ and the corresponding standard doses (250, 300, 350, 400 mg) were identified. Th…

GanciclovirCytotoxic drugSterilityDrug CompoundingDrug StorageGrowth promotion030226 pharmacology & pharmacyAntiviral AgentsStandard PreparationsExtended storage03 medical and health sciences0302 clinical medicineAnimal scienceDrug StabilityRefrigerationMedicineInfusions Parenteral030212 general & internal medicineGeneral Pharmacology Toxicology and PharmaceuticsGanciclovirDrug PackagingRetrospective StudiesOriginal Researchbusiness.industryReproducibility of ResultsRoboticsRobotic systemsAseptic processingbusinessDrug ContaminationPharmacy Service Hospitalmedicine.drugEuropean journal of hospital pharmacy : science and practice
researchProduct

Comparative analysis of DNA breakage, chromosomal aberrations and apoptosis induced by the anti-herpes purine nucleoside analogues aciclovir, gancicl…

2002

Nucleoside analogues have been used in antiviral therapy and suicide cancer gene therapy. Therefore, it is of importance to compare their potential cytotoxic and genotoxic action. Using metabolically competent CHO cells expressing the thymidine kinase gene of herpes simplex virus type 1 (CHO-HSVtk cells) as a model system, the induction of DNA breaks was compared with the induction of structural chromosomal aberrations and apoptosis/necrosis after exposure to the anti-herpes nucleoside analogues aciclovir (ACV), ganciclovir (GCV) and penciclovir (PCV). After continuous treatment of CHO-HSVtk cells with the drugs, LD(10) in a colony-forming assay was 50, 0.5 and 1 microM for ACV, GCV and PCV…

GanciclovirGuanineDNA damagevirusesHealth Toxicology and MutagenesisAcyclovirApoptosisCHO CellsBiologymedicine.disease_causeAntiviral AgentsThymidine KinaseChromosomesColony-Forming Units AssayNecrosisCricetulusCricetinaeGeneticsmedicineCytotoxic T cellAnimalsSimplexvirusAciclovirEnzyme InhibitorsMolecular BiologyGanciclovirChromosome AberrationsDNAMolecular biologyHerpes simplex virusApoptosisPenciclovirNucleosidemedicine.drugDNA DamageMutation research
researchProduct